Handbook of Pediatric Epilepsy Case Studies, Second Edition Maria Augusta Montenegro Install Download
Handbook of Pediatric Epilepsy Case Studies, Second Edition Maria Augusta Montenegro Install Download
https://ebookmeta.com/product/handbook-of-pediatric-epilepsy-
case-studies-second-edition-maria-augusta-montenegro/
https://ebookmeta.com/product/handbook-of-pediatric-epilepsy-
case-studies-2nd-edition-maria-augusta-montenegro/
https://ebookmeta.com/product/common-pitfalls-in-epilepsy-case-
based-learning-1st-edition-dieter-schmidt/
https://ebookmeta.com/product/handbook-of-pediatric-surgery-2nd-
edition-chandrasen-k-sinha/
https://ebookmeta.com/product/2023-cfa-program-curriculum-level-
ii-volume-3-corporate-issuers-and-equity-valuation-1st-edition-
cfa-institute/
Easy Sorbet Cookbook: 50 Delicious Sorbet Recipes (2nd
Edition) Booksumo Press
https://ebookmeta.com/product/easy-sorbet-cookbook-50-delicious-
sorbet-recipes-2nd-edition-booksumo-press/
https://ebookmeta.com/product/bitty-fish-barbara-derubertis-eva-
vagreti-cockrille/
https://ebookmeta.com/product/easy-catfish-cookbook-a-seafood-
cookbook-with-delicious-catfish-recipes-2nd-edition-booksumo-
press/
https://ebookmeta.com/product/cartography-visualization-of-
geospatial-data-4th-edition-menno-jan-kraak/
https://ebookmeta.com/product/fake-crowne-the-crowne-
brothers-4-a-fake-relationship-romance-cd-reiss/
The Mate Challenge BBW Paranormal Shape Shifter Romance
Sassy Mates Book 4 1st Edition Milly Taiden
https://ebookmeta.com/product/the-mate-challenge-bbw-paranormal-
shape-shifter-romance-sassy-mates-book-4-1st-edition-milly-
taiden-2/
HANDBOOK OF PEDIATRIC
EPILEPSY CASE STUDIES,
SECOND EDITION
EDITED BY
MARIA AUGUSTA MONTENEGRO
AND JONG M. RHO
CRC Press
Taylor & Fr is Group
Handbook of Pediatric
Epilepsy Case Studies,
Second Edition
Research in the field of epilepsy will continue at a rapid pace, with the ultimate hope
of curing many intractable epilepsy syndromes. Fully updated, this new edition is
organized chronologically, from neonate through adolescence, and the handbook is
the culmination of a group effort involving leading physicians and researchers whose
contributions constitute a concise and practical reference for health professionals in
training. Here the contributors review the recent flood of new information on the
pathophysiology, genetics, and treatment of the various epilepsy syndromes, and the
volume is distilled into an easy-to-use guide.
Edited by
Maria Augusta Montenegro
UC Sand Diego School of Medicine
Jong M. Rho
UC San Diego School of Medicine
Second edition published 2023
by CRC Press
6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL 33487-2742
© 2023 selection and editorial matter, Maria Augusta Montenegro and Jong M. Rho; individual
chapters, the contributors
First edition published by CRC Press | Taylor and Francis, LLC 2008
Reasonable efforts have been made to publish reliable data and information, but the author and
publisher cannot assume responsibility for the validity of all materials or the consequences of
their use. The authors and publishers have attempted to trace the copyright holders of all material
reproduced in this publication and apologize to copyright holders if permission to publish in this
form has not been obtained. If any copyright material has not been acknowledged please write and
let us know so we may rectify in any future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced,
transmitted, or utilized in any form by any electronic, mechanical, or other means, now known
or hereafter invented, including photocopying, microfilming, and recording, or in any information
storage or retrieval system, without written permission from the publishers.
For permission to photocopy or use material electronically from this work, access www.
copyright.com or contact the Copyright Clearance Center, Inc. (
CCC), 222 Rosewood Drive,
Danvers, MA 01923, 978-
750-
8400. For works that are not available on CCC please contact
[email protected]
Trademark notice: Product or corporate names may be trademarks or registered trademarks and are
used only for identification and explanation without intent to infringe.
DOI: 10.1201/9781003296478
Typeset in Times
by codeMantra
Contents
Preface.......................................................................................................................xi
Authors ................................................................................................................... xiii
Abbreviations & Acronyms ..................................................................................... xv
Contributors ............................................................................................................xix
v
vi Contents
Chapter 11 Self-Limited
Neonatal Epilepsy Syndromes .................................... 107
Maria Augusta Montenegro and Jong M. Rho
Chapter 12 Self-Limited
(Familial)
Infantile Epilepsy ...................................... 113
Heather Pekeles and Kenneth A. Myers
Chapter 15 Hypoxic-Ischemic
Encephalopathy (Neonatal
Seizures) ................. 129
Jeffrey J. Gold
Chapter 18 Genetic Epilepsy with Febrile Seizures Plus (GEFS+) .................... 149
Michaela Castello and Aliya Frederick
Contents vii
Chapter 28 Sturge–Weber
Syndrome.................................................................. 223
Sabrina Tavella-Burka and Ajay Gupta
Chapter 35 Lennox–Gastaut
Syndrome .............................................................. 265
Jong M. Rho
Chapter 37 Landau-Kleffner
Syndrome ............................................................. 277
Frank M. C. Besag
Chapter 38 Developmental/Epileptic
Encephalopathy with Spike-and-Wave
Activation in Sleep (D/EE-SWAS)...................................................
283
Kevin Chapman
Chapter 40 Anti-NMDA
Receptor Encephalitis ................................................. 299
Jennifer Yang and Jennifer Graves
Contents ix
Chapter 53 Sleep-Related
Hypermotor Epilepsy ................................................ 387
Kevin Chapman
xi
xii Preface
Jong M. Rho, MD
Rady Children’s Hospital
University of California San Diego
Authors
Maria Augusta Montenegro is a pediatric neurologist and epileptologist currently
working at Rady Children’s Hospital/ University of California San Diego School of
Medicine. Her clinical expertise is in pediatric epilepsy, with an emphasis on epilep-
tic encephalopathy and EEG. She completed medical school, residency, and Ph.D.
at the University of Campinas (Brazil) and a postdoctorate research fellowship at
Columbia University (NY). Prior to her current position, she held an academic fac-
ulty appointment at the University of Campinas (Brazil) where she was the head of
Pediatric Neurology.
xiii
Abbreviations & Acronyms
AAN American Academy of Neurology
ACMG American College of Medical Genetics and Genomics
ACTH adrenocorticotropic hormone
ADHD attention deficit hyperactivity disorder
ADME absorption, distribution, metabolism, and excretion
ADNFLE autosomal dominant nocturnal frontal lobe epilepsy
ANT anterior nucleus of the thalamus
ASM antiseizure medication
BECTS benign epilepsy with centrotemporal spikes
BIPDs bilateral independent periodic discharges
BOLD blood-oxygen-level-dependent
CAE childhood absence epilepsy
CBT cognitive-behavioral
therapy
CBZ carbamazepine
CEEG continuous EEG monitoring
CI confidence interval
CIV continuous intravenous
CIVASM continuous intravenous antiseizure medication
CMA chromosomal microarray analysis
CNS central nervous system
CNVs copy number variants
COVE childhood occipital visual epilepsy
CSE convulsive status epilepticus
CSTB cystatin B
CSWS continuous spike-and-wave
during sleep
CYP cytochrome P450
DBS deep brain stimulation
DEE developmental and/or epileptic encephalopathy
DEE-SWAS
developmental epileptic encephalopathy with spike-and-wave
activation in sleep
DEND developmental delay, epilepsy, and neonatal diabetes
DNA deoxyribonucleic acid
DNT dysembryoplastic neuroepithelial tumor
EAF epilepsy with auditory features
ECoG electrocorticography
ED emergency department
EEG electroencephalogram
EIDEE early infantile developmental and epileptic encephalopathy
EIMFS epilepsy of infancy with migrating focal seizures
EMAS epilepsy with myoclonic-atonic
seizures
EME early myoclonic epilepsy
ES exome sequencing
xv
xvi Abbreviations & Acronyms
MEG magnetoencephalography
MEI myoclonic epilepsy of infancy
MELAS mitochondrial encephalomyopathy, lactic acidosis, and stroke-like
episodes
MERRF myoclonus, epilepsy, with ragged red fibers
mFCD minimal focal cortical dysplasia
MgFUS MRI-guided
focused ultrasound
MgLITT MRI-guided laser interstitial thermal therapy
MGP multigene panels
MHD monohydroxy derivative
MOGHE mild malformation of cortical development with oligodendroglial
hyperplasia and epilepsy
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
MS myoclonic
MS-MLPA
methylation-sensitive multiplex ligation-dependent
probe
amplification
mtDNA mitochondrial DNA
MTLE-HS mesial temporal lobe epilepsy with hippocampal sclerosis
mTOR mammalian target of rapamycin
MTS mesial temporal sclerosis
nAChR neuronal nicotinic acetylcholine receptor
NCS nonconvulsive seizures
NCSE nonconvulsive status epilepticus
NDDs neurodevelopmental disorders
nDNA nuclear DNA
NGS next-generation
sequencing
NICU neonatal intensive care unit
NLSTEPSS North London Status Epilepticus Surveillance Study
NMDA N-methyl-D-aspartate
NMDAR N-methyl-D-aspartate
receptor
NORSE new-onset refractory status epilepticus
NREM nonrapid eye movement
OCP oral contraceptives
OSA obstructive sleep apnea
PCR polymerase chain reaction
PDMS patient data management system
PHACE posterior fossa anomalies, hemangioma, arterial anomalies, cardiac
anomalies, and eye anomalies
PICU pediatric intensive care unit
PLEDs periodic lateralizing epileptiform discharges
PME progressive myoclonus epilepsy
PNES psychogenic nonepileptic seizures
POLE photosensitive occipital lobe epilepsy
POLG polymerase gamma
ppm parts per million
xviii Abbreviations & Acronyms
xix
xx Contributors
Olivia Kim-McManus
Yu-tze
Ng
UC San Diego School of Medicine The Children’s Hospital of San Antonio
San Diego, California and Baylor College of Medicine
Houston, Texas
Joerg Klepper
Children’s Hospital Aschaffenburg Douglas R. Nordli, Jr.
Aschaffenburg, Germany University of Chicago Medicine
Chicago, Illinois
Contributors xxi
June Yoshii-Contreras
Mary L. Zupanc
UC San Diego School of Medicine UC Irvine
San Diego, California Orange County, California
Ifrah Zawar
UVA Health
Charlottesville, Virginia
Section I
The Basics
1 A Pediatric Epilepsy
Primer
James W. Owens
University of Washington
CONTENTS
Pediatric Epilepsy Is Common...................................................................................4
.
Pediatric Epilepsy Encompasses a Wide Range of Disorders....................................4
Pediatric Epilepsy Viewed from a Developmental Context ....................................... 8
A Wide Range of Treatment Options Are Available .................................................. 9
Pediatric Epilepsy Is Not Just about Seizures .......................................................... 10
Summary .................................................................................................................. 11
Suggested References............................................................................................... 11
DOI: 10.1201/9781003296478-2 3
4 Handbook of Pediatric Epilepsy Case Studies, Second Edition
F IGURE 1.1 MRI images and EEG data from a teenager with structural focal epilepsy. This
15-year-old
right-handed boy had left-sided
hemiplegic cerebral palsy and startle-induced
focal impaired awareness (previously referred to as complex partial) seizures. Panels A and
B are representative T1-weighted postcontrast MRI images (axial and coronal planes, respec-
tively) demonstrating the damage caused by an in utero right middle cerebral artery territory
infarction (the left side of the image corresponds to the right side of the brain). Panel C shows
the patient’s EEG immediately prior to and following an auditory startle as well as several
seconds into his typical electrographic ictal discharge. Note the high-amplitude slow activ-
ity with superimposed faster frequencies in the leads labeled Fp2–F4, F4– C4, and C4–P4
indicating that the seizure is arising from the right frontocentral region (by convention, EEG
leads with even numbers are on the right and those with odd numbers are on the left; Fp,
frontal polar; F, frontal; C, central; and P, parietal). The patient underwent definitive surgical
resection and became seizure free.
8 Handbook of Pediatric Epilepsy Case Studies, Second Edition
clinical phenomena – often associated with a particular age of onset. For example,
West syndrome represents the combination of epileptic spasms (a particular type of
seizure), an interictal EEG pattern called hypsarrhythmia, and developmental arrest
or regression with a peak age of onset between 3 and 7 months of age. Although
still clinically diverse, epilepsy syndromes seem to represent a more homogeneous
clinical population than is afforded by the ILAE classification scheme. For example,
childhood absence and juvenile myoclonic epilepsy are both categorized as genetic
generalized epilepsies, but they differ significantly in their age of onset, predominant
seizure type, and rate of remission.
Overall, approximately 60% of patients will become seizure free with one of the
first two ASMs prescribed. Unfortunately, for those whose epilepsy does not respond,
the chance of treatment success with subsequent medication trials becomes progres-
sively less. For this reason, patients who do not respond to one of the first two or three
medications are referred to as “pharmaco-resistant”,
“drug-resistant”,
“medically
refractory”, and “medically intractable”. Fortunately, there is an ever-increasing
range of options for patients with medically intractable epilepsy. One possibility is
the use of the ketogenic diet: a high-fat and low-carbohydrate therapy which results
in increased ketone body production by the liver and produces improved seizure
control through as yet undefined mechanisms.
For certain carefully selected patients, the best option is epilepsy surgery: e.g.,
neurosurgical removal of the epileptogenic zone in the cortex. Examples of such
procedures range from focal neocortical resection for patients with an area of corti-
cal dysplasia, to removal of the anterior temporal lobe in patients with temporal lobe
epilepsy, and to hemispherectomy in patients with hemimegaloencephaly. Epilepsy
surgery candidates undergo an extensive presurgical evaluation that includes neuro-
imaging, EEG monitoring, and detailed neuropsychological studies, as well as other
ancillary tests. Given the irreversible nature of surgical intervention, it is vital to
determine whether potential functional deficits might result from the proposed resec-
tion. Still, for excellent candidates, the chance of becoming seizure-free following
surgery is as high as 65%–70% depending principally on location of the focus and
whether or not there exist clear imaging findings related to that focus. At times,
surgical procedures are conducted with a goal of decreasing seizure frequency or
for palliation. This may involve, for example, partial resection of a lesion, if the pres-
ence of eloquent cortex prevents complete removal, or corpus callosotomy to prevent
generalization of seizure activity from one hemisphere to the other.
Another surgical option used to decrease seizure frequency is implantation of a
VNS device. This device consists of a generator implanted subcutaneously over the
pectoral muscle and is connected via leads wrapped around the left vagus nerve. The
VNS has an adjustable stimulation cycle, which delivers pulses of defined intensity
and duration to the vagus nerve. For unknown reasons, such stimulation significantly
decreases seizure frequency in approximately 50% of patients.
Although unlikely to make a patient seizure free, the VNS may significantly
improve seizure control. A unique responsive neurostimulator (RNS), which detects
seizure activity and utilizes cortical stimulation to abort focal seizures, is now in
routine use in adult epilepsy and is being used with greater frequency in children.
Deep brain stimulation of targets in the thalamus is similarly being employed to
treat severe pharmacoresistant epilepsy. As the range of therapeutic interventions
for medically intractable epilepsy expands, it becomes ever more vital to refer such
patients to a comprehensive epilepsy center where the possible use of such therapies
can be considered.
medical conditions, patients with epilepsy have a lower rate of successful educational
completion, employment, marriage, and other important quality-of-life measures.
Rates of affective disorders and behavioral problems are also much higher than in
the general population. Interestingly, this remains true even for patients with epilepsy
that readily comes under medical control, as well as patients who undergo successful
epilepsy surgery.
Certainly, many patients with epilepsy do extremely well, yet it remains trou-
bling that there are those who do not. For some, frequent seizures can result in an
encephalopathy that interferes with psychosocial function. Also, as ASMs generally
work by increasing inhibition or decreasing excitation, cognitive dysfunction is not
an infrequent side effect. Also, there are psychiatric problems such as depression
and anxiety, and attentional deficits. Still, another aspect of this multifactorial phe-
nomenon is the fact that epilepsy reflects, at some level, neuronal dysfunction. It is
therefore perhaps not surprising that patients with epilepsy also may have difficulties
with other cortically and subcortically mediated processes. This possibility is further
suggested by the finding that neurobehavioral problems in children with epilepsy
precede the diagnosis of epilepsy approximately 25% of the time. Regardless of the
underlying pathophysiology, it is crucial that we consider such comorbidities in car-
ing for our patients with epilepsy.
SUMMARY
Given the relatively high incidence of epilepsy, all physicians who work with chil-
dren, regardless of specialty, will encounter patients afflicted with this heterogeneous
disorder (more accurately termed, “epilepsies”). Appropriate care of these patients
is crucial given the potential developmental consequences of both the underlying
epileptogenic process, as well as those of the treatments we employ. The therapeutic
armamentarium available to neurologists and epileptologists continues to expand as
does our understanding of the basic neurobiology of these conditions. Yet, as we
work with our patients to make them seizure free, we must also be continually cog-
nizant of the wide-ranging effects of the epilepsies and avoid focusing solely on the
seizures themselves.
SUGGESTED REFERENCES
Austin J., Harezlak J., Dunn D., Huster G., Rose D., Ambrosius W. Behavior problems in chil-
dren before first recognized seizures. Pediatrics 2001; 107:115–22.
Baker G. Depression and suicide in adolescents with epilepsy. Neurology 2006; 66 (Suppl
3):S5–S12.
Bender R., Baram T. Epileptogenesis in the developing brain: What can we learn from animal
models? Epilepsia 2007; 48(Suppl
5):2–6.
Devinsky O., Vezzani A., O’Brien T.J., Jette N., Scheffer I.E., de Curtis M., Perucca P. Epilepsy.
Nat Rev Dis Primers 2018; 4:18024.
Dubé C.M., McClelland S., Choy M., Brewster A.L., Noam Y., Baram T.Z. Fever, febrile
seizures and epileptogenesis. In: Noebels J.L., Avoli M., Rogawski M.A., Olsen R.W.,
Delgado-Escueta
A.V., editors. Jasper’s Basic Mechanisms of the Epilepsies [Internet].
4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.
12 Handbook of Pediatric Epilepsy Case Studies, Second Edition
Fisher R.S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E., Engel Jr. J.,
Forsgren L., French J.A., Glynn M., Hesdorffer D.C., Lee B.I., Mathern G.W., Moshé
S.L., Perucca E., Scheffer I.E., Tomson T., Watanabe M., Wiebe S. ILAE official report:
A practical clinical definition of epilepsy. Epilepsia 2014; 55(4):475–82.
Fisher R.S., Cross J.H., French J.A., Higurashi N., Hirsch E., Jansen F.E., Lagae L., Moshé
S.L., Peltola J., Roulet Perez E., Scheffer I.E., Zuberi S.M. Operational classification of
seizure types by the International League Against Epilepsy: Position paper of the ILAE
Commission for Classification and Terminology. Epilepsia 2017; 58:522–30.
Frank N.A., Greuter L., Guzman R., Soleman J. Early surgical approaches in pediat-
ric epilepsy - a systematic review and meta-analysis. Childs Nerv Syst 2022. doi:
10.1007/s00381-022-05699-x.
Galanopoulou A. Developmental patterns in the regulation of chloride homeostasis and
GABAA receptor signaling by seizures. Epilepsia 2007; 48(Suppl 5):14–8.
Hauser W., Annegers J., Kurland L. Incidence of epilepsy and unprovoked seizures in
Rochester, Minnesota: 1935–1984. Epilepsia 1993; 34:453–68.
Kho L., Lawn N., Dunne J., Linto J. First seizure presentation: Do multiple seizures within
24 hours predict recurrence? Neurology 2006; 67:1047–9.
Gedzelman E.R., Meador K.J. Neurological and psychiatric sequelae of developmental expo-
sure to antiepileptic drugs. Front Neurol 2012; 3:182.
Guerrini R., Conti V., Mantegazza M., Balestrini S., Galanopoulou A.S., Benfenati F.
Developmental and epileptic encephalopathies: From genetic heterogeneity to pheno-
typic continuum. Physiol Rev 2023; 103(1):433–513.
Kriegstein A., Noctor S. Patterns of neuronal migration in the embryonic cortex. Trends
Neurosci 2004; 27:392–9.
Kwan P., Brodie M. Early identification of refractory epilepsy. N Engl J Med 2000; 342:314–9.
Lizana J., Garcia E., Marina L., Lopez M., Gonzalez M., Hoyos A. Seizure recurrence alter a
first unprovoked seizure in childhood: A prospective study. Epilepsia 2000; 41:1005–13.
Pohlmann-Eden B., Beghi E., Camfield C., Camfield P. The first seizure and its management
in adults and children. BMJ 2006; 332:339–42.
Rogawski M.A., Löscher W., Rho J.M. Mechanisms of action of antiseizure drugs and the
ketogenic diet. Cold Spring Harb Perspect Med 2016; 6(5):a022780.
Sankar R., Rho J. Do seizures affect the developing brain? Lessons from the laboratory. J Child
Neurol 2007; 22 (Suppl):21S–29S.
Scheffer I.E., Berkovic S., Capovilla G., Connolly M.B., French J., Guilhoto L., Hirsch E., Jain
S., Mathern G.W., Moshé S.L., Nordli D.R., Perucca E., Tomson T., Wiebe S., Zhang
Y.H., Zuberi S.M. ILAE classification of the epilepsies: Position paper of the ILAE com-
mission for classification and terminology. Epilepsia 2017; 58:512–21.
Tellez-Zenteno J., Dhar R., Wiebe S. Long-term seizure outcomes following epilepsy surgery:
A systematic review and meta-analysis. Brain 2005; 128:1188–98.
Tsou A.Y., Kessler S.K., Wu M., Abend N.S., Massey S., Treadwell J.R. Surgical treatments
for epilepsies in children aged 1–36 Months: A systematic review. Neurology 2022 Oct
21. doi: 10.1212/WNL.0000000000201012.
Velísková J., Claudio O.I., Galanopoulou A.S., Lado F.A., Ravizza T., Velísek L., Moshé S.L.
Seizures in the developing brain. Epilepsia 2004; 45(Suppl
8):6–12.
2 Epilepsy Genetics Primer
Kimberly Wiltrout
Boston Children’s Hospital
Annapurna Poduri
Boston Children’s Hospital
CONTENTS
Epilepsy Genetics Principles.................................................................................... 13
Utility of Genetic Testing ......................................................................................... 15
Genetic Testing Methods ......................................................................................... 15
Choosing Genetic Tests for Patients with Epilepsies ............................................... 18
Interpretation of the Genetic Testing Results ........................................................... 19
The Importance of Pre- and Posttest Genetic Counseling .......................................20
Conclusions ..............................................................................................................20
Suggested References...............................................................................................20
Genetics has long been recognized as having an important causal role in epilepsy.
From the first gene discoveries of familial epilepsies in the 1990s to now, there has
been rapid growth in the identification of monogenic causes of epilepsy as well as in
the delineation of the principles underlying the genetics of epilepsy. In this chapter,
we will highlight the advances in clinical practice that have come from the growth
of epilepsy genetics and will review the principles that guide a rational approach to
genetic testing in epilepsy.
DOI: 10.1201/9781003296478-3 13
14 Handbook of Pediatric Epilepsy Case Studies, Second Edition
IGURE 2.1 Timeline of epilepsy gene discoveries during the past 25 years. (Created by
F
Alfred George and reprinted with permission from Poduri et al., 2021, How We Got to Where
We’re Going, Elements in Genetics of Epilepsy.)
differences in copy number compared to the reference genome. CNVs mainly consist
of microdeletions and microduplications. Other less common types of genetic varia-
tion associated with epilepsy include trinucleotide repeat expansions and genomic
imprinting, which is an epigenetic phenomenon.
Familial segregation and twin studies provided the first evidence for genetic causes
of familial epilepsy. De novo variants are variants that are considered new in an
individual and are detectable in the individual but not detected in their parents when
DNA is assayed, typically from peripheral blood leukocytes or buccal samples. De
novo variants have been demonstrated to play an important role in causing epilepsy,
particularly in the case of developmental and epileptic encephalopathies (DEEs).
De novo variants most often arise during meiosis during the formation of the
oocyte or spermatocyte, and so are present starting from the individual’s zygote stage
and should be detectable in a blood sample. A de novo variant may also occur in the
postzygotic stage, with the implication that it is present in only a fraction of cells
and may potentially be restricted to only the brain or only certain neuron popula-
tions in the brain. These mosaic variants may not be detectable with the routine
DNA analysis of blood leukocytes. This phenomenon of somatic mosaicism has been
demonstrated to be a mechanism for focal cortical dysplasia, hemimegalencephaly,
and other brain malformations that have an association with epilepsy. Genetic testing
may only be successful at identifying the causative variant if performed on the brain
tissue removed during epilepsy surgery. Rarely, mosaicism has occurred in a par-
ent’s oocytes or spermatocytes, meaning that multiple eggs or sperm may have the
Epilepsy Genetics Primer 15
variant but the rest of the parent’s cells do not, resulting in “negative” testing from
DNA assayed in leukocytes and an apparently de novo testing result but a slightly
higher (1%–10%) risk of recurrence in offspring compared to a truly de novo variant
in which only one oocyte or spermatocyte had the variant DNA.
For most familial epilepsies and de novo epilepsies identified during the initial
periods of gene discovery, the genetic causes have been monogenic, meaning the
causal variant is in a single gene and follows basic inheritance patterns of autoso-
mal dominant, autosomal recessive, X-linked, etc. However, for many of the com-
mon, more drug-responsive forms of epilepsy, such as genetic generalized epilepsies
(GGEs), efforts to identify monogenic causes have not been as successful, and there
is likely a multifactorial etiology that involves risk incurred from multiple gene vari-
ants, called “polygenic risk,” and possibly epigenetic factors. The understanding of
these polygenic and epigenetic risk factors is still in its infancy, and their clinical
applicability has not yet been established.
TABLE 2.1
Genetic Epilepsies and Syndromes with Epilepsy as a Prominent Feature in
Which Genetic Etiology Influences Treatment and Trial Eligibility
Gene Treatment
ALDH7A1 Pyridoxine
CAD Uridine
CHRNA4, CHRNB2, and CHRNA2 Potential precision therapy: transdermal nicotine
CLN2 Cerliponase alfa to delay motor impairment
DEPDC5, NPRL2, and NPRL3 Potential precision therapy: mTOR inhibitors
GRIN1, GRIN2A, GRIN2B, and GRIN2D Potential precision therapy: memantine, dextromethorphan
for gain-of-function
variants
KCNQ2 Sodium channel-blocking ASMs generally helpful. Potential
precision therapy: ezogabine (in trial currently)
KCNT1 and KCNT2 Potential precision therapy: quinidine for gain-of-function
variants
MECP2 Symptomatic treatments and trials ongoing
PNPO Pyridoxal 5-phosphate
PRRT2 Carbamazepine helpful
SCN1A Avoid sodium channel-blocking
ASMs (generally)
Potential precision therapy: fenfluramine and stiripentol
SCN2A Sodium channel blocking ASM for gain-of-function
variants. Generally, avoid sodium channel blocking ASM
for loss-of-function
variants
SCN8A Sodium channel blocking ASM for gain-of-function
variants
Potential precision therapy: Trials ongoing
SLC2A1 Ketogenic diet
TSC1 and TSC2 Vigabatrin for infantile spasms
Precision therapy: mTOR inhibitors
CDKL5 Ganaxolone
UBE3A Potential precision therapy: trials ongoing
consider the phenotype of the individual and decide the test most likely to target the
genes associated with the phenotype:
• Karyotype
Karyotypes are images of a person’s chromosomes isolated from an indi-
vidual cell and arranged in pairs in numerical order based on size and band-
ing patterns to look for abnormalities in chromosome number or structure.
Historically, karyotypes have been used for identification of chromosomal aber-
rations in those with dysmorphic features or congenital anomalies (e.g., trisomy
21). However, chromosomal microarray analysis (CMA) has largely replaced
the karyotype as the preferred modality in these situations due to greater resolu-
tion. Karyotype remains useful in epilepsy genetics evaluation if there is sus-
picion of a complex chromosomal rearrangement, such as a ring chromosome.
Epilepsy Genetics Primer 17
any variants identified during testing. Exome sequencing allows for the
option of reanalysis in the future if negative.
• Genome Sequencing
Genome sequencing (GS) includes sequencing of the entire human
genome, including the coding sequences, as well as the noncoding regions,
and can detect SNVs, insertions/deletions, CNVs, and structural variants.
GS has the potential to yield more variants of uncertain significance (VUS)
than other methods, making a trio-based approach a key component of vari-
ant interpretation. GS is a more expensive testing method that is not often
covered by insurance, but, as has been experienced with the other testing
methods, the costs are expected to decline over time. As analysis methods
develop, we anticipate more detection of noncoding variants in the regions
of known genes and novel genes.
• Other
In specific cases, additional targeted genetic testing may be required,
guided by epilepsy-related phenotypes that suggest specific syndromes or
genes.
TABLE 2.2
Diagnostic Yield of Genetic Testing Techniques in Epilepsy
Diagnostic Yield
GS provide the additional benefit of opportunity for reanalysis after an initial nega-
tive test. The yield of CMA is higher in those with epilepsy and dysmorphic features
or other systemic abnormalities, supporting the use of CMA earlier in the diagnostic
testing algorithm for these individuals.
researchers to combine individuals with variants in the gene and evaluate for any
potential gene–disease
relationships.
If no genetic cause is identified, there may still be a genetic cause, but it has not yet
been identified by the methods used in testing. If one is still suspicious of a genetic
cause, a new technique may be employed to detect different types of variants, or if
some time has passed, a benefit from improvement in technology. Reanalysis of ES
or GS data after an appropriate time interval has also been shown to be successful
at identifying causative genetic variants, as the scientific knowledge of gene variants
continues to grow.
CONCLUSIONS
Genetic testing has an established role in the evaluation of familial epilepsy and
drug-resistant and early-onset epilepsy, and the understanding of the role of genet-
ics in more common, non-drug-resistant epilepsy continues to grow. The pace of
new discoveries in the genomics of epilepsy continues to be rapid. Genetic testing is
becoming routine in the care of patients with epilepsy, presenting a challenge even to
the well-informed neurologist, who must triage individuals who might benefit from
testing, determine the appropriate and available tests, partner with genetic counsel-
ors or geneticists to consent patients and families, and interpret and explain findings,
as well as implement the findings into a treatment plan that includes expanding prog-
nostic and therapeutic implications.
SUGGESTED REFERENCES
Benke T.A., Park K., Krey I., Camp C.R., Sojng R., Ramsey A.J., Yuan H., Traynelis S.F.,
Lemke J. Clinical and therapeutic significance of genetic variation in the GRIN gene
family encoding NMDARs. Neuropharmacology 2021;199: 108805.
Epilepsy Genetics Primer 21
Beygo J., Buiting K., Ramsden S.C., Ellis R., Clayton-Smith J., Kanber D. Update of the
EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and
Angelman syndromes. Eur J Hum Genet 2019;27: 1326–40.
Borlot F., Abushama A., Morrison-Levy N., Jain P., Puthenveettil Vinayan K., Abukhalid M.,
Aldhalaan H.M., Almuzaini H.S., Gulati S., Hershkovitz T., Konanki R., Lingappa
L., Luat A.F., Shafi S., Tabarki B., Thomas M., Yoganathan S., Alfadhel M., Arya R.,
Donner E.J., Ehaideb S.N., Gowda V.K., Jain V., Madaan P., Myers K.A., Otsubo H.,
Panda P., Sahu J.K., Sampaio L.P.B., Sharma S., Simard-Tremblay E., Zak M., Whitney
R. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Epilepsia 2020;61: 679–92.
Chandrasekar I., Tourney A., Loo K., Carmichael J., James K., Ellsworth K.A., Dimmock D.,
Joseph M. Hemimegalencephaly and intractable seizures associated with the NPRL3
gene variant in a newborn: A case report. Am J Med Genet A 2021;185: 2126–30.
Chintalaphani S.R., Pineda S.S., Deveson I.W., Kumar K.R. An update on the neurological
short tandem repeat expansion disorders and the emergence of long-read sequencing
diagnostics. Acta Neuropathol Commun 2021;9: 98.
Chou I.C., Lin S.S., Lin W.D., Wang C.H., Chang Y.T., Tsai F.J., Tsai C.H. Successful control
with carbamazepine of family with paroxysmal kinesigenic dyskinesia of PRRT2 muta-
tion. Biomedicine (Taipei)
2014;4: 15.
Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo
mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of
infancy. Am J Hum Genet 2001;68: 1327–32.
Coughlin 2nd C.R., Tseng L.A., Abdenur J.E., Ashmore C., Boemer F., Bok L.A., Boyer M.,
Buhas D., Clayton P.T., Das A., Dekker H., Evangeliou A., Feillet F., Footitt E.J., Gospe
Jr. S.M., Hartmann H., Kara M., Kristensen E., Lee J., Lilje R., Longo N., Lunsing R.J.,
Mills P., Papadopoulou M.T., Pearl P.L., Piazzon F., Plecko B., Saini A.G., Santra S.,
Sjarif D.R., Stockler-Ipsiroglu S., Striano P., Van Hove J.L.K., Verhoeven-Duif N.M.,
Wijburg F.A., Zuberi S.M., van Karnebeek C.D.M. Consensus guidelines for the diagno-
sis and management of pyridoxine-dependent epilepsy due to α-aminoadipic
semialde-
hyde dehydrogenase deficiency. J Inherit Metab Dis 2021;44: 178–92.
Cowley M.J., Liu Y.C., Oliver K.L., Carvill G., Myers C.T., Gayevskiy V., Delatycki M.,
Vlaskamp D.R.M., Zhu Y., Mefford H., Buckley M.F., Bahlo M., Scheffer I.E., Dinger
M.E., Roscioli T. Reanalysis and optimisation of bioinformatic pipelines is critical for
mutation detection. Hum Mutat 2019;40: 374–9.
Djémié T., Weckhuysen S., von Spiczak S., Carvill G.L., Jaehn J., Anttonen A.K., Brilstra
E., Caglayan H.S., de Kovel C.G., Depienne C., Gaily E., Gennaro E., Giraldez B.G.,
Gormley P., Guerrero-López R., Guerrini R., Hämäläinen E., Hartmann C., Hernandez-
Hernandez L., Hjalgrim H., Koeleman B.P., Leguern E., Lehesjoki A.E., Lemke J.R.,
Leu C., Marini C., McMahon J.M., Mei D., Møller R.S., Muhle H., Myers C.T., Nava C.,
Serratosa J.M., Sisodiya S.M., Stephani U., Striano P., van Kempen M.J., Verbeek N.E.,
Usluer S., Zara F., Palotie A., Mefford H.C., Scheffer I.E., De Jonghe P., Helbig I., Suls
A., EuroEPINOMICS‐RES Dravet working group. Pitfalls in genetic testing: The story
of missed SCN1A mutations. Mol Genet Genomic Med 2016;4: 457–64.
Epilepsy Genetics Initiative. The epilepsy genetics initiative: Systematic reanalysis of diagnos-
tic exomes increases yield. Epilepsia 2019;60: 797–806.
Epilepsy Phenome/Genome Project EiKC. Diverse genetic causes of polymicrogyria with epi-
lepsy. Epilepsia 2021;62: 973–83.
Franz D.N., Lawson J.A., Yapici Z., Ikeda H., Polster T., Nabbout R., Curatolo P., de Vries P.J.,
Dlugos D.J., Herbst F., Peyrard S., Pelov D., French J.A. Adjunctive everolimus therapy
for tuberous sclerosis complex-associated refractory seizures: Results from the postex-
tension phase of EXIST-3. Epilepsia 2021;62: 3029–41.
22 Handbook of Pediatric Epilepsy Case Studies, Second Edition
French J.A., Lawson J.A., Yapici Z., Ikeda H., Polster T., Nabbout R., Curatolo P., de Vries
P.J., Dlugos D.J., Berkowitz N., Voi M., Peyrard S., Pelov D., Franz D.N. Adjunctive
everolimus therapy for treatment-resistant focal-onset seizures associated with tuber-
ous sclerosis (EXIST-3): A phase 3, randomised, double-blind, placebo-controlled study.
Lancet 2016;388: 2153–63.
Fu C., Armstrong D., Marsh E., Lieberman D., Motil K., Witt R., Standridge S., Nues P., Lane
J., Dinkel T., Coenraads M., von Hehn J., Jones M., Hale K., Suter B., Glaze D., Neul J.,
Percy A., Benke T. Consensus guidelines on managing Rett syndrome across the lifes-
pan. BMJ Paediatr Open 2020;4: e000717.
Guerrini R., Dravet C., Genton P., Belmonte A., Kaminska A., Dulac O. Lamotrigine and sei-
zure aggravation in severe myoclonic epilepsy. Epilepsia 1998;39: 508–12.
Helbig I., Ellis C.A. Personalized medicine in genetic epilepsies - Possibilities, challenges, and
new frontiers. Neuropharmacology 2020;172: 107970.
Hong W., Haviland I., Pestana-Knight E., Weisenberg J.L., Demarest S., Marsh E.D., Olson
H.E. CDKL5 deficiency disorder-related epilepsy: A review of current and emerging
treatment. CNS Drugs 2022;36: 591–604.
Ibañez K., Polke J., Hagelstrom R.T., Dolzhenko E., Pasko D., Thomas E.R.A., Daugherty L.C.,
Kasperaviciute D., Smith K.R.; WGS for Neurological Diseases Group, Deans Z.C., Hill
S., Fowler T., Scott R.H., Hardy J., Chinnery P.F., Houlden H., Rendon A., Caulfield
M.J., Eberle M.A., Taft R.J., Tucci A.; Genomics England Research Consortium. Whole
genome sequencing for the diagnosis of neurological repeat expansion disorders in
the UK: A retrospective diagnostic accuracy and prospective clinical validation study.
Lancet Neurol 2022;21: 234–45.
Ivy A.S., Standridge S.M. Rett syndrome: A timely review from recognition to current clinical
approaches and clinical study updates. Semin Pediatr Neurol 2021;37: 100881.
Johannesen K.M., Liu Y., Koko M., Gjerulfsen C.E., Sonnenberg L., Schubert J., Fenger
C.D., Eltokhi A., Rannap M., Koch N.A., Lauxmann S., Krüger J., Kegele J.,
Canafoglia L., Franceschetti S., Mayer T., Rebstock J., Zacher P., Ruf S., Alber M.,
Sterbova K., Lassuthová P., Vlckova M., Lemke J.R., Platzer K., Krey I., Heine C.,
Wieczorek D., Kroell-Seger J., Lund C., Klein K.M., Au P.Y.B., Rho J.M., Ho A.W.,
Masnada S., Veggiotti P., Giordano L., Accorsi P., Hoei-Hansen C.E., Striano P.,
Zara F., Verhelst H., Verhoeven J.S., Braakman H.M.H., van der Zwaag B., Harder
A.V.E., Brilstra E., Pendziwiat M., Lebon S., Vaccarezza M., Le N.M., Christensen
J., Grønborg S., Scherer S.W., Howe J., Fazeli W., Howell K.B., Leventer R.,
Stutterd C., Walsh S., Gerard M., Gerard B., Matricardi S., Bonardi C.M., Sartori S.,
Berger A., Hoffman-Zacharska D., Mastrangelo M., Darra F., Vøllo A., Motazacker
M.M., Lakeman P., Nizon M., Betzler C., Altuzarra C., Caume R., Roubertie A.,
Gélisse P., Marini C., Guerrini R., Bilan F., Tibussek D., Koch-Hogrebe M., Perry
M.S., Ichikawa S., Dadali E., Sharkov A., Mishina I., Abramov M., Kanivets I.,
Korostelev S., Kutsev S., Wain K.E., Eisenhauer N., Wagner M., Savatt J.M., Müller-
Schlüter K., Bassan H., Borovikov A., Nassogne M.C., Destrée A., Schoonjans A.S.,
Meuwissen M., Buzatu M., Jansen A., Scalais E., Srivastava S., Tan W.H., Olson
H.E., Loddenkemper T., Poduri A., Helbig K.L., Helbig I., Fitzgerald M.P., Goldberg
E.M., Roser T., Borggraefe I., Brünger T., May P., Lal D., Lederer D., Rubboli G.,
Heyne H.O., Lesca G., Hedrich U.B.S., Benda J., Gardella E., Lerche H., Møller R.S.
Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and
therapeutic implications. Brain 2021;145: 2991–3009.
Kalachikov S., Evgrafov O., Ross B., Winawer M., Barker-Cummings C., Martinelli Boneschi
F., Choi C., Morozov P., Das K., Teplitskaya E., Yu A., Cayanis E., Penchaszadeh G.,
Kottmann A.H., Pedley T.A., Hauser W.A., Ottman R., Gilliam T.C. Mutations in LGI1
cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002;30:
335–41.
Epilepsy Genetics Primer 23
Klepper J., Akman C., Armeno M., Auvin S., Cervenka M., Cross H.J., De Giorgis V., Della
Marina A., Engelstad K., Heussinger N., Kossoff E.H., Leen W.G., Leiendecker B.,
Monani U.R., Oguni H., Neal E., Pascual J.M., Pearson T.S., Pons R., Scheffer I.E.,
Veggiotti P., Willemsen M., Zuberi S.M., De Vivo D.C. Glut1 Deficiency Syndrome
(Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS
study group. Epilepsia Open 2020;5: 354–65.
Kobow K., Reid C.A., van Vliet E.A., Becker A.J., Carvill G.L., Goldman A.M., Hirose S.,
Lopes-Cendes I., Khiari H.M., Poduri A., Johnson M.R., Henshall D.C. Epigenetics
explained: A topic “primer” for the epilepsy community by the ILAE Genetics/Epigenetics
Task Force. Epileptic Disord 2020;22: 127–41.
Koch J., Mayr J.A., Alhaddad B., Rauscher C., Bierau J., Kovacs-Nagy R., Coene K.L., Bader
I., Holzhacker M., Prokisch H., Venselaar H., Wevers R.A., Distelmaier F., Polster T.,
Leiz S., Betzler C., Strom T.M., Sperl W., Meitinger T., Wortmann S.B., Haack T.B. CAD
mutations and uridine-responsive epileptic encephalopathy. Brain 2017;140: 279–286.
Lai D., Gade M., Yang E., Koh H.Y., Lu J., Walley N.M., Buckley A.F., Sands T.T., Akman
C.I., Mikati M.A., McKhann G.M., Goldman J.E., Canoll P., Alexander A.L., Park
K.L., Von Allmen G.K., Rodziyevska O., Bhattacharjee M.B., Lidov H.G.W., Vogel
H., Grant G.A., Porter B.E., Poduri A.H., Crino P.B., Heinzen E.L. Somatic variants in
diverse genes leads to a spectrum of focal cortical malformations. Brain 2022;145(8):
2704–2720.
Leu C., Stevelink R., Smith A.W., Goleva S.B., Kanai M., Ferguson L., Campbell C., Kamatani
Y., Okada Y., Sisodiya S.M., Cavalleri G.L., Koeleman B.P.C., Lerche H., Jehi L.,
Davis L.K., Najm I.M., Palotie A., Daly M.J., Busch R.M.; Epi25 Consortium, Lal D.
Polygenic burden in focal and generalized epilepsies. Brain 2019;142: 3473–81.
Lossius K., de Saint Martin A., Myren-Svelstad S., Bjørnvold M., Minken G., Seegmuller C.,
Valenti Hirsch M.P., Chelly J., Steinlein O., Picard F., Brodtkorb E. Remarkable effect
of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-
related hypermotor epilepsy. Epilepsy Behav 2020;105: 106944.
Millichap J.J., Park K.L., Tsuchida T., Ben-Zeev B., Carmant L., Flamini R., Joshi N.,
Levisohn P.M., Marsh E., Nangia S., Narayanan V., Ortiz-Gonzalez X.R., Patterson
M.C., Pearl P.L., Porter B., Ramsey K., McGinnis E.L., Taglialatela M., Tracy M., Tran
B., Venkatesan C., Weckhuysen S., Cooper E.C. KCNQ2 encephalopathy: Features,
mutational hot spots, and ezogabine treatment of 11 patients. Neurol Genet 2016;2: e96.
Mills P.B., Camuzeaux S.S., Footitt E.J., Mills K.A., Gissen P., Fisher L., Das K.B., Varadkar
S.M., Zuberi S., McWilliam R., Stödberg T., Plecko B., Baumgartner M.R., Maier O.,
Calvert S., Riney K., Wolf N.I., Livingston J.H., Bala P., Morel C.F., Feillet F., Raimondi
F., Del Giudice E., Chong W.K., Pitt M., Clayton P.T. Epilepsy due to PNPO mutations:
Genotype, environment and treatment affect presentation and outcome. Brain 2014;137:
1350–60.
Mole S.E., Schulz A., Badoe E., Berkovic S.F., de Los Reyes E.C., Dulz S., Gissen P., Guelbert
N., Lourenco C.M., Mason H.L., Mink J.W., Murphy N., Nickel M., Olaya J.E., Scarpa
M., Scheffer I.E., Simonati A., Specchio N., Von Löbbecke I., Wang R.Y., Williams R.E.
Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2
disease patients. Orphanet J Rare Dis 2021;16: 185.
Møller R.S., Liebmann N., Larsen L.H.G., Stiller M., Hentschel J., Kako N., Abdin D., Di
Donato N., Pal D.K., Zacher P., Syrbe S., Dahl H.A., Lemke J.R. Parental mosaicism in
epilepsies due to alleged de novo variants. Epilepsia 2019;60: e63–e66.
Moloney P.B., Dugan P., Widdess-Walsh P., Devinsky O., Delanty N. Genomics in the presur-
gical epilepsy evaluation. Epilepsy Res 2022;184: 106951.
Northrup H., Aronow M.E., Bebin E.M., Bissler J., Darling T.N., de Vries P.J., Frost M.D.,
Fuchs Z., Gosnell E.S., Gupta N., Jansen A.C., Jóźwiak S., Kingswood J.C., Knilans
T.K., McCormack F.X., Pounders A., Roberds S.L., Rodriguez-Buritica D.F., Roth J.,
24 Handbook of Pediatric Epilepsy Case Studies, Second Edition
Sampson J.R., Sparagana S., Thiele E.A., Weiner H.L., Wheless J.W., Towbin A.J.,
Krueger D.A.; International Tuberous Sclerosis Complex Consensus Group. Updated
international tuberous sclerosis complex diagnostic criteria and surveillance and man-
agement recommendations. Pediatr Neurol 2021;123: 50–66.
Oliver K.L., Ellis C.A., Scheffer I.E., Ganesan S., Leu C., Sadleir L.G., Heinzen E.L., Mefford
H.C., Bass A.J., Curtis S.W., Harris R.V.; Epi4K Consortium, Whiteman D.C., Helbig
I., Ottman R., Epstein M.P., Bahlo M., Berkovic S.F. Common risk variants for epi-
lepsy are enriched in families previously targeted for rare monogenic variant discovery.
EBioMedicine 2022;81: 104079.
Perucca P., Scheffer I.E. Genetic contributions to acquired epilepsies. Epilepsy Curr 2021;21:
5–13.
Peters L., Depienne C., Klebe S. Familial adult myoclonic epilepsy (FAME): Clinical fea-
tures, molecular characteristics, pathophysiological aspects and diagnostic work-up.
Medizinische Genetik 2021;33: 311–8.
Poduri A.H., George J., Alfred L., Heinzen E.L., Lowenstein D., James S. (editors). How We
Got to Where We’re Going. Cambridge: Cambridge University Press, 2021.
Retterer K., Scuffins J., Schmidt D., Lewis R., Pineda-Alvarez D., Stafford A., Schmidt L.,
Warren S., Gibellini F., Kondakova A., Blair A., Bale S., Matyakhina L., Meck J.,
Aradhya S., Haverfield E. Assessing copy number from exome sequencing and exome
array CGH based on CNV spectrum in a large clinical cohort. Genet Med 2015;17:
623–629.
Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M.,
Lyon E., Spector E., Voelkerding K., Rehm H.L.; ACMG Laboratory Quality Assurance
Committee. Standards and guidelines for the interpretation of sequence variants: A joint
consensus recommendation of the American College of Medical Genetics and Genomics
and the Association for Molecular Pathology. Genet Med 2015;17: 405–24.
Riggs E.R., Andersen E.F., Cherry A.M., Kantarci S., Kearney H., Patel A., Raca G., Ritter
D.I., South S.T., Thorland E.C., Pineda-Alvarez D., Aradhya S., Martin C.L. Technical
standards for the interpretation and reporting of constitutional copy-number variants: A
joint consensus 11recommendation of the American College of Medical Genetics and
Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med 2020;22:
245–57.
Rochtus A., Olson H.E., Smith L., Keith L.G., El Achkar C., Taylor A., Mahida S., Park M.,
Kelly M., Shain C., Rockowitz S., Rosen Sheidley B., Poduri A. Genetic diagnoses
in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Epilepsia
2020;61: 249–58.
Sánchez Fernández I., Loddenkemper T., Gaínza-Lein M., Sheidley B.R., Poduri A. Diagnostic
yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study. Neurology
2019;92: e418–e428.
Sheidley B.R., Malinowski J., Bergner A.L., Bier L., Gloss D.S., Mu W., Mulhern M.M.,
Partack EJ, Poduri A. Genetic testing for the epilepsies: A systematic review. Epilepsia
2022;63: 375–87.
Shoubridge C., Fullston T., Gécz J. ARX spectrum disorders: Making inroads into the molecu-
lar pathology. Hum Mutat 2010;31: 889–900.
Spector E., Behlmann A., Kronquist K., Rose N.C., Lyon E., Reddi H.V.; ACMG Laboratory
Quality Assurance Committee. Laboratory testing for fragile X, 2021 revision: A tech-
nical standard of the American College of Medical Genetics and Genomics (ACMG).
Genet Med 2021;23: 799–812.
Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R.,
Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine
receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe
epilepsy. Nat Genet 1995;11: 201–3.
Epilepsy Genetics Primer 25
Vanoye C.G., Desai R.R., Ji Z., Adusumilli S., Jairam N., Ghabra N., Joshi N., Fitch E., Helbig
K.L., McKnight D., Lindy A.S., Zou F., Helbig I., Cooper E.C., George Jr. A.L. High-
throughput evaluation of epilepsy-associated KCNQ2 variants reveals functional and
pharmacological heterogeneity. JCI Insight. 2022; 7: e156314.
Vawter-Lee M., Franz D.N., Fuller C.E., Greiner H.M. Clinical Letter: A case report of tar-
geted therapy with sirolimus for NPRL3 epilepsy. Seizure 2019;73: 43–45.
Virtaneva K., D’Amato E., Miao J., Koskiniemi M., Norio R., Avanzini G., Franceschetti S.,
Michelucci R., Tassinari C.A., Omer S., Pennacchio L.A., Myers R.M., Dieguez-Lucena
J.L., Krahe R., de la Chapelle A., Lehesjoki A.E. Unstable minisatellite expansion caus-
ing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 1997;15: 393–6.
Wallace R.H., Scheffer I.E., Barnett S., Richards M., Dibbens L., Desai R.R., Lerman-Sagie
T., Lev D., Mazarib A., Brand N., Ben-Zeev B., Goikhman I., Singh R., Kremmidiotis
G., Gardner A., Sutherland G.R., George Jr. A.L., Mulley J.C., Berkovic S.F. Neuronal
sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures
plus. Am J Hum Genet 2001;68: 859–65.
Wilson J.L., Gregory A., Kurian M.A., Bushlin I., Mochel F., Emrick L., Adang L.; BPAN
Guideline Contributing Author Group, Hogarth P., Hayflick S.J. Consensus clinical man-
agement guideline for beta-propeller protein-associated neurodegeneration. Dev Med
Child Neurol 2021;63: 1402–9.
Wolff M., Johannesen K.M., Hedrich U.B.S., Masnada S., Rubboli G., Gardella E., Lesca G.,
Ville D., Milh M., Villard L., Afenjar A., Chantot-Bastaraud S., Mignot C., Lardennois
C., Nava C., Schwarz N., Gérard M., Perrin L., Doummar D., Auvin S., Miranda M.J.,
Hempel M., Brilstra E., Knoers N., Verbeek N., van Kempen M., Braun K.P., Mancini
G., Biskup S., Hörtnagel K., Döcker M., Bast T., Loddenkemper T., Wong-Kisiel L.,
Baumeister F.M., Fazeli W., Striano P., Dilena R., Fontana E., Zara F., Kurlemann G.,
Klepper J., Thoene J.G., Arndt D.H., Deconinck N., Schmitt-Mechelke T., Maier O.,
Muhle H., Wical B., Finetti C., Brückner R., Pietz J., Golla G., Jillella D., Linnet K.M.,
Charles P., Moog U., Õiglane-Shlik E., Mantovani J.F., Park K., Deprez M., Lederer D.,
Mary S., Scalais E., Selim L., Van Coster R., Lagae L., Nikanorova M., Hjalgrim H.,
Korenke G.C., Trivisano M., Specchio N., Ceulemans B., Dorn T., Helbig K.L., Hardies
K., Stamberger H., de Jonghe P., Weckhuysen S., Lemke J.R., Krägeloh-Mann I., Helbig
I., Kluger G., Lerche H., Møller R.S. Genetic and phenotypic heterogeneity suggest
therapeutic implications in SCN2A-related disorders. Brain 2017;140: 1316–36.
Xu Y., Song R., Chen W., Strong K., Shrey D., Gedela S., Traynelis S.F., Zhang G., Yuan H.
Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Ann Clin Transl Neurol 2021;8: 1480–94.
Yuskaitis C.J., Ruzhnikov M.R.Z., Howell K.B., Allen I.E., Kapur K., Dlugos D.J., Scheffer
I.E., Poduri A., Sherr E.H. Infantile spasms of unknown cause: Predictors of outcome
and genotype-phenotype
correlation. Pediatr Neurol 2018;87: 48–56.
Another Random Scribd Document
with Unrelated Content
Joseph Rose, son of William B. Horton and Mary Rose, born in
Sheshequin, when his father was but sixteen years old; married Anna
Lorinda Shores, daughter of Caleb Shores and Anna Horton, and born
on Shores' Hill, 31 July, 1821. They live in Waverly, N. Y., and have
two children, Sophia and Melinda; Sophia married Smith Barnum—
reside in Litchfield; Melinda remains unmarried.
Joseph R. Horton possesses more than ordinary intellectual
capacity, and is highly respected and esteemed. He was a faithful
Union soldier in the war of the Rebellion, and lost a leg in the
service.
Third Generation.—Caleb I.
I. Barnabas, son of Caleb Horton I. and Abigail Hallock, born at
Cutchogue, L. I., Sept., 1666; married about 1686, Sarah Hines.
Children, all born at Cutchogue:
1. Caleb, born 1687; married Phebe Terry. 2. Barnabas. 3. Penelope. 4.
Bethia.
I. David, son of David Horton and Mary Horton (Caleb I.), born at
Cutchogue, in 1697; married about 1720, perhaps, to Eliza Sweazy,
daughter of Richard Sweazy.
Children, all born at Cutchogue:
1. Richard, born in 1720; married, probably, Mehitabel Jayne. 2. Mary, born
in 1724. 3. Abigail. 4. John.
Fifth Generation.—Caleb I.
I. Caleb, son of Caleb Horton and Phebe Terry (Barnabas, Caleb
I.), born in Southold in 1715; married in April, 1737, to Sarah
Benjamin, born in 1717. They moved to Chester, N. J., about 1748.
Children, all born in Southold, except Sally and Mary, who were
born in Chester:
1. Caleb, born in 1738. 2. Richard. 3. Stephen. 4. Justin. 5. Patty. 6. Sally. 7.
Mary, married Richard Terry.
IV. Nathan, son of Caleb Horton and Phebe Terry, born in Southold
about 1725; married about 1749, to Mehetabel Case, of Southold.
They moved to Chester, N. J., soon after marriage. He was a soldier
and a captain in the Revolutionary war.
Children, all born in Chester, or Black River, Morris Co., N. J.:
1. Israel, born 1750; died young. 2. Jemima, married Houston, or Hughson;
lived at Mount Highest, N. J. 3. David, no record. 4. Nathan, born 25 Feb.,
1757; married Elizabeth Eagles. 5. Bethia, married Caleb Terry, of Black River.
6. Sarah, married Daniel Sweazy. 7. Zephaniah, born 13 Nov., 1760; married
Jane McCurry. 8. Phineas, born 17 Feb., 1774; married 1. Bethia Luce; 2.
Esther Horton.
VI. Elijah, son of Caleb Horton and Phebe Terry, born in Southold,
19 June, 1724; married Lydia Sweazy, daughter of Joseph Sweazy,
and born in Southold about 1731. They moved to Roxbury, now
Chester, N. J., in 1748. He died 7 Oct., 1799. She died 18 March,
1723. He was a Justice of the Peace, of fair reputation, and much
respected.
Children, all born in Chester:
1. Barnabas, born 27 Sept., 1749; married Elizabeth Coleman, or Corwin. 2.
Elijah, born 19 Dec., 1756; married Lydia Sweazy. 3. Silas, born 17 July, 1746:
married 1. Susan Corwin; 2. Mary Kelsey; 3. Esther Horton.
II. David, son of Barnabas Horton and Mary Sweazy, born about
1724; married 31 May, 1744, Mary Warner. They settled in the town
of Goshen about 1760. He was a warm Whig, was one of the signers
of the Pledge of Independence for the Colonies in 1775.
Children:
1. David, born about 1745; married 29 Oct., 1773, Theodosia Allen. 6.
Dorothy, born 3 April, 1756; married Eli Corwin.
III. Mathias, son of Barnabas Horton and Mary Sweazy, born about
1726; married about 1750, and had Mathias, born in Goshen in
1751, and others, names not known.
IV. Elihu, son of Barnabas Horton and Mary Sweazy, born about
1728; married Colman, and had one child, which died young. He was
a true patriot, and signed the Pledge of Independence in 1775.
Dea. Nathaniel Horton was one of the excellent of the earth, loved
by all.
Daniel Horton was a Justice of the Peace for many years, of fair
reputation and much respected.
IV. Col. Nathan, son of Capt. Nathan Horton and Mehitabel Case,
born in Chester, N. J., 25 Feb., 1757; married in New York City, 10
July, 1783, to Elizabeth Eagles, daughter of John Eagles and Hannah
——, and born in the city of New York, 1 Dec., 1766. They moved to
North Carolina about 1785, and settled on New River, then Wilkes,
now Watauga Co., N. C.
Children, probably, all born at New River, except—
1. Hannah, born at Chester, 15 Dec., 1784; and died at Hagerstown, Md.,
while on the way to North Carolina. 2. William, born 15 August, 1786; married
Milley Dula. 3. James, born 28 Feb., 1789; married Sydnia Webb. 4. David
Eagles, born 4 May, 1792; married Sarah Dula. 5. Phineas, born 9 Jan., 1795;
married Sarah Councill. 6. Sarah, born 19 Sept., 1797; died of croup when
young. 7. John, born 11 June, 1800; died of croup when young. 8. Elizabeth,
born 15 Sept., 1803; married Zephaniah Horton, Jr., of Yancey Co. 9. Jonathan,
born 26 Feb., 1806; married Malinda Hartzag.
I. Israel, Jr., first son of Lieut. Israel Horton and Sarah Lee
(Jonathan, Jonathan, Caleb I.), born in Cutchogue, Southold, 23
Sept., 1756. He died at Phelps, Ontario Co., N. Y., 22 July, 1813. She
died Jan., 1842. He moved with his father from Southold to Goshen,
N. Y., in 1762. At the death of his father he was about 15 years old,
and he being the oldest of the family, remained with his mother, and
assisted in taking care of the family. On the 23 Feb., 1780, he
married Anna Van Devort; she was the daughter of Thomas Van
Devort, and was born in Orange Co., N. Y., 29 Nov., 1763. He
removed from Orange County to Owego, N. Y., about 1801 or 1802,
and in 1816 from Owego to Phelps, Ontario Co., N. Y., where he
settled permanently, and spent the remainder of his days. They were
pious people and members of the Methodist Episcopal Church.
Children:
1. Jason, born in Orange Co., N. Y., 23 Feb., 1781; married Sally Miller, of
Geneva. 2. William Lee, born in Orange County, New York, 21 October, 1781. 3.
Sarah, born in Orange County, New York, 9 April, 1784; married in Phelps,
1813, Samuel Minnis. 4. Phebe, born in Orange Co., N. Y., 6 March, 1786;
married Frederick Schenick, of Spencer, N. Y. 5. John, born in Orange Co., N. Y.,
26 Feb., 1788; married Rachel Hiler. 6. Thomas Van Devort, born in Orange
Co., N. Y., 6 April, 1790; died 21 July, 1811. 7. Benjamin, born in Orange Co., N.
Y., 9 Sept., 1792; died 22 Sept., 1834. 8. Arietta, born in Orange Co., N. Y., 28
Nov., 1794; married Isaac Butler. 9. Peter Davis, born in Orange Co., N. Y., 11
Dec., 1796; married Hannah Couch. 10. Isaac T., born in Orange Co., N. Y., 28
Feb., 1799; married Esther Clark. 11. Eleanor, born in Owego, N. Y., 27 Dec.,
1802; married Thomas Van Devort. 12. Cornelius, born in Owego, N. Y., 13
Aug., 1804; died unmarried. 13. Joseph Lee, born in Owego, N. Y., 9 July,
1807; married widow Elizabeth Hatfield.
II. Jason, son of Lieut. Israel Horton and Sarah Lee, born at
Cutchogue, Southold, L. I., 18 Dec., 1758; married in 1783, to Mary
Terry, daughter of Uriah Terry and Abigail Cleveland, and born in
Southold, L. I., in 1760. He was a clothier by trade, served his
apprenticeship in Chester, and then settled for a short time at
Boskenridge,—it is now Basking Ridge,—New Jersey, and then
moved to Somerville, New Jersey, where he settled permanently and
where he died. He was one of the most pious and exemplary men
that ever lived, a zealous, active, intelligent Presbyterian. He was a
very strict observer of the Sabbath, and violation of it by his
neighbors always gave him great displeasure. Observing one of his
neighbors frequently chopping firewood on the Sabbath, he went
one Saturday afternoon and took his neighbor a load of wood
prepared for the fire, telling him it was to save him the trouble of
chopping his firewood on the Sabbath. His neighbor took it kindly,
and was careful afterwards to see that his fuel was all ready
beforehand for the Sabbath. It was a common remark of one of the
most reckless men of Somerville, that "If all professors of religion
would live like Old Jason Horton, he would believe there was some
reality in religion."
Jason Horton never failed to exert a strong influence for the
Christian religion as long as he lived. And his wife also was a true
help-meet for him in this regard, possessing genuine piety and
Christian activity. She died at Somerville, on Sabbath morning at 5
o'clock, 22 Aug., 1841.
Children:
1. Uriah, born in Sugar Loaf, Orange Co., N. Y., in 1784; married Elizabeth
Fairchild. 2. Sarah, born 20 Jan., 1788; married William Guest. 3. Elizabeth,
married 1. John Denniston; 2. Adam Huyler. 4. Mary, born in 1793. 5. Abigail,
born in Somerville, 6 March, 1795. 6. Eunice, born in 1797. 7. Fanny, born in
1799. 8. Israel, born in 1801; died young.
III. Jeremiah, son of Lieut. Israel Horton and Sarah Lee, born at
Cutchogue, L. I., 24 Oct., 1759. He lived with his grandfather Lee on
Long Island, until he was sixteen years old, and then came to
Orange Co. On the 16th of Jan., 1783, he married Mary Goldsmith.
One of his hips was injured by sciatic rheumatism in early life,
causing him to be a cripple all his days. He was a stone-mason and
farmer, and notwithstanding he was lame, he still performed a great
amount of manual labor. He was a man of good judgment, and a
Justice of the Peace for many years, and was a man greatly beloved
and respected in the community. He and his wife were both
members of the Presbyterian Church. They settled in Blooming
Grove, about a mile and a quarter south of the present village of
Washingtonville, and he built, mostly with his own hands, the
venerable old stone mansion now occupied by the widow and family
of his only son Benjamin G. Horton. Jeremiah Horton died 17 Sept.,
1841. His wife died 10 June, 1833.
Children, all born in Blooming Grove:
1. Julia, died young. 2. Fanny, died young. 3. Eunice, born 2 March, 1791. 4.
Susan, born 17 Oct., 1793. 5. Mary, born 23 Oct., 1795. 6. Sarah, born 15
March, 1797. 7. Lydia, 24 April, 1799. 8. Eliza, died young. 9. Amy, born 17
Nov., 1803. 10. Benjamin G., born 28 August, 1807.
IV. Eunice, daughter of Lieut. Israel Horton and Sarah Lee, born at
Southold in 1761; married George Howell. They moved from Orange
Co., in early life, and settled at Peach Orchard, Seneca Co., N. Y.
Children:
1. Benjamin. 2. William. 3. Jeremiah. 4. George. 5. Samuel. 6. Lucinda. 7.
Anna. 8. Jemima. 9. Mehitabel. 10. Sally. 11. Hannah. 12. Eliza.
V. Maj. John, son of Lieut. Israel Horton and Sarah Lee, born in
Goshen, 30 July, 1763. He married in Little Britain, Orange Co., N. Y.,
9 April, 1785, Deborah Terry, daughter of Parshall Terry and Deborah
Clark, born in Little Britain, Orange Co., N. Y., on the 25 day of May,
1766. She was one of the inmates of the famed Forty Fort the night
after the Indian battle and massacre of Wyoming. She was the
tender and affectionate mother of eleven children, and raised them
all to maturity. They moved to Wyoming Valley in 1787, and in 1792
moved to Terrytown, Pa., where he bought land and settled
permanently, and where he died on the 28th day of April, 1848,
aged almost 85 years, and where she died on the 25th day of May,
1844, aged 78 years.
Major Horton built the first framed dwelling-house on the west
side of the river in the township of then Wyalusing, now Terry. He
was the owner of the first two-horse wagon ever brought into
Terrytown, and that wagon not only cheerfully bore the burdens he
put upon it, but also those of several of the neighbors. He also
owned the first fanning mill ever brought into the place. He built the
first frame barn that was ever built in the township. It was built in
1805, and is still in a good state of preservation, and is owned by
Edmund Horton.
The framed house mentioned above, built by Major Horton in
1806, accidentally took fire on the 23 Sept., 1861, and was burned
up. Major Horton was a wagoner in the Revolutionary War, towards
the close of the war, and was stationed in Mamakating Hollow, and
afterwards on the Neversink Creek, not far from the present Port
Jervis. He was Major of a battalion of militia in Wyalusing, frequently
held township offices, and was one of the leading men of the place.
He was not a public professor of Christianity, but his life in the main
was in harmony with its teachings, and he loved, and was
successful, in promoting good order in society. He was universally
esteemed, and at his funeral a larger concourse of people were
gathered than had ever before been witnessed in this part of the
country on a funeral occasion. Deborah, his wife, was a woman
distinguished for her eminent piety, unwearied industry, and good
economy; she knew well how to guide the house. Their children
were all born at Terrytown, except Ebenezer, who was born in Little
Britain, N. Y., and Anna and Lydia, who were born in Wyoming
Valley.
Children:
1. Ebenezer, born 9 Jan., 1786; married Mary Terry. 2. Anna, born 21 Oct.,
1788; died August, 1813; unmarried. 3. Lydia, born 14 March, 1791; married
John P. Stalford. 4. John, born 23 March, 1793; married 1. Nancy Miller; 2.
Lydia Molther; 3. Amanda Cross. 5. Eunice, born 14 Jan., 1796; married
Thomas Ingham. 6. Sallie, born 29 May, 1798; married John Morrow. 7. Betsey,
born 27 Dec., 1800; married Francis Baillet. 8. Francis, born 7 June, 1803; died
unmarried. 9. George F., born 2 Jan., 1806; married Abigail Terry. 10. Edmund,
born 9 August, 1808; married Martha A. Robinson. 11. Harry Morgan, born 24
Sept., 1811; unmarried.
VI. Joseph Lee, son of Lieut. Israel Horton and Sarah Lee, born in
Goshen, N. Y., 27 April, 1765; married in Sugar Loaf, N. Y., 27 Feb.,
1791, to Hannah Todd, daughter of Joseph Todd, of Sugar Loaf, and
born there on the 31 Aug., 1771. He died in Palmyra, 10 July, 1831.
She died at the same place on 9 Aug., 1827.
He moved from Goshen, N. Y., soon after he was married, to
Owego, N. Y., where he remained until 1803, and he then removed
to Palmyra, N. Y., and took up land and settled about four miles
north of the village, where Mrs. Sarah Durfee, one of his daughters,
now resides.
Joseph L. Horton and his wife were very pious people, both
worthy members of the Baptist Church, beloved and respected in the
community. He was a farmer and shoemaker. He had feeble health
for several years before his death, wasting away gradually by
consumption. He was a very patient and industrious man, and
towards the close of his life, suffering from the ravages of disease,
and much enfeebled, he would still work at his occupation, making
sometimes one shoe in a day, and at others only half a one,
according as he had strength and breath. His end was peace.
Children:
1. Samuel Todd, born at Owego, N. Y., 27 July, 1792. 2. Catharine, born at
Owego, N. Y., 21 May, 1794; married Geo. Spinner; he died without issue. 3.
Henry Wisner, born at Owego, N. Y., 31 May, 1797. 4. Sarah Parshall, born at
Owego, N. Y., 28 May, 1799. 5. James Parshall, born at Owego, N. Y., 5 April,
1801. 6. Millie Ann, born at Palmyra, N. Y., 20 July, 1803; died 7 Oct., 1818. 7.
Lewis Beers, born at Palmyra, N. Y., 24 May, 1806. 8. Anna, born at Palmyra, N.
Y., 5 July, 1808. 9. Durfee Delano, born at Palmyra, N. Y., 25 July, 1813. 10.
Wilson Osborn, born at Palmyra, N. Y., 26 April, 1815.
VII. Mary, daughter of Lieut. Israel Horton and Sarah Lee, born
near Goshen, N. Y., about 1767; married John Clark. Settled in
Spencer, N. Y.
Children:
John, Benjamin, Ann, Sally, and others.
VIII. Samuel, son of Lieut. Israel Horton and Sarah Lee, born in the
township of Goshen, N. Y., in the year 1770. He was a master builder
in the city of New York, when quite a young man. He was said to
possess a mind peculiarly adapted to mechanical pursuits, and he
engaged in them before his majority. When about 23 years of age,
he took the small-pox, in New York, went home to his father's, in
Orange County, where he died in a few days.
IX. Benjamin, youngest child of Lieut. Israel Horton and Sarah Lee,
was born at Sugar Loaf, N. Y., 7 Feb., 1772. He was married in
Belvale, Orange Co., N. Y., 29 Jan., 1795, by the Rev. Mr. Stevens, to
Hannah Vance. She was born in Belvale, N. Y., 28 March, 1777. He
bought a farm and settled there, but by indorsing for a friend, he
lost his farm and all that he had. He then, about 1822, removed to
New York, and entered largely into the business of a master builder.
In 1834 he moved to Milan, Ohio, where, on the 18th Feb., 1856, he
died, of congestion of the lungs. His wife died at the same place, 25
June, 1860. He and his wife were both members of the M. E.
Church.
Children:
1. Margaret Vance, born 9 Dec., 1796. 2. Milton, born 7 April, 1799. 3. Julia
Ann E., born 12 May, 1800; died of consumption, in Ohio, 27 Nov., 1839;
unmarried. 4. Samuel, born 28 July, 1802; died 21 Nov., 1841, of epilepsy and
consumption; unmarried. 5. Nicholas Townsend, born in Belvale, 20 Jan., 1805;
married Sarah Van Orden. 6. Sarah Jane, born in Belvale, 2 May, 1807; married
Matthew Mead, and settled in Philadelphia, Pa. 7. Eliza, born in Belvale, 19
March, 1809; died of lock-jaw, 18 July, 1815. 8. Hannah Maria, born in Belvale,
7 May, 1811; married James Galloway Horton. 9. Catharine D., born in Belvale,
13 Aug., 1813; married Enoch Nichols. 10. Elizabeth R., born in Belvale, 3 Oct.,
1815; married Smith Conley. 11. Eunice, born in Belvale, 6 Oct., 1817; died 8
Oct., 1826, of dysentery. 12. Eloise, born in Belvale, 19 May, 1822; died 2 Oct.,
1843, of consumption; unmarried.
III. Silas, son of Elijah Horton and Lydia Sweazy, born in Chester,
17 July, 1764; married 1. Susan Corwin, who died 9 July, 1790,
leaving Lydia Corwin Horton, who married Isaac H. Corwin, and died
in 1816, childless. He married 2. Mary Kelsey, born in Goshen, 26
Jan., 1770; died 21 Dec., 1803, without issue. He married 3. Esther
Horton, daughter of Dea. Nathaniel Horton, and had
Mary, born 8 Sept., 1811; died 8 Oct., 1811.
By 2d wife:
4. Elisha, born about 1798; died without issue. 5. Barnabas, born about
1800; married Ruth Cramer. 6. Archibald, born about 1802; married Matilda
Smith. 7. Joanna, born about 1804; married David Horton Lewis. 8. Celestia,
born about 1807; married John Cooper Horton. 9. Lydia, born about 1809;
married Daniel Horton; no issue.
Nancy Cramer Horton died, and he married the widow Maria Craig,
and she died without children by him. He married next the widow,
Pamela Smith; she died leaving no children by him. He married, for his
fourth wife, Jane Hawk, and by her he had one son, viz.: William.
Edward Horton died 6 Feb., 1835. His wife died 10 Sept., 1872, at
the remarkable age of 97 years and 21 days. In her funeral
procession were four generations of her descendants. They were
both buried in Brutus, N. Y.
Of the above children, the first to ninth, inclusive, were by his 1st
wife, she died 30 Jan., 1814. In 1815, he married 2. Mary Calender,
and she had the 10, 11, 12, and 13 of the above children, and died
in Sept., 1826, and in August, 1827, he married 3. Ann Purdy, by
whom he had the three last children.
Silas Danes Horton was a farmer, upright, honest, and a man of
more than ordinary mental capacity. He was a deacon of the Old
School Baptist Church at the time of his death, and for many years
before. He wrote frequently on religious subjects, and many of his
articles appeared in the "Signs of the Times" a religious paper edited
and published by the Rev. G. Beebee, of Middletown, N. Y.
Dea. Horton was one of the pillars of the church, greatly esteemed
by his fellow-citizens, and his death, which occurred 21 Sept., 1850,
was deeply lamented.
II. Barnabas, son of Silas Horton and Mary Danes, born in Wallkill,
in 1780; married about 1804, Jerusha Wheat; she died and he
married 2.
Children, born in Wallkill, and all by his first wife:
1. Loton, married Adeline Horton. 2. Harrison, married Prudence Warner. 3.
Anna, married Alanson Beeks. 4. Milicent, married Chauncey Horton, son of
Gilbert, son of Frederick. 5. Alfred M., married Adaline Wheat, they were
double cousins; had Silas Danes, and others. 6. Gabriel C., married 1. Mary Ann
Slawon; 2. Elizabeth Thompson; he had Loton, by his 1st wife, and Horace and
Gilbert, by 2d wife.
He died in Lansing, N. Y., 16 Sept., 1821. After his death his widow
married a Taylor; she died in Watkins, N. Y., 19 Dec., 1861.
II. William Lee, son of Israel Horton and Anna Van Devort, born in
Orange Co., N. Y., 21 Oct., 1782; married Eunice Tracey, of Spencer,
N. Y.
Children:
1. James Parshall. 2. Lydia Ann, married Shepherd. 3. Caroline, married
Harmer. 4. Charlotte, J., married Raymond. 5. Sarah R., married Nichols. 6.
Clark, married, had sons, Henry N. and Elliott.
III. Sarah, daughter of Israel Horton and Anna Van Devort, born in
Orange Co., N. Y., 9 April, 1784; married in Phelps, in 1813, to Samuel
Minnis. She died 8 May, 1864, in Wyalusing, Bradford Co., Pa.; she
was a quiet Christian woman, much esteemed by all who knew her.
Her husband died in comparatively early life, leaving her with a
family of children, and not much of this world's goods to help herself
with. But by industry and care she managed to raise and educate
her children. She was living with one of them, viz., Maria Homet, of
Wyalusing, Pa., at the time of her death. In her early life she was
very active—often rode on horseback—and at one time she made a
trip on horseback and alone, from Phelps to Wyalusing, about three
hundred miles circular.
Children, born at Phelps:
1. William. 2. and 3. (twins) Maria, married Edward Homet; Rachael, married
Stephen Spoor. 4. Ellen, married Jacob Hicks. 5. Willard, born in 1823; died
young.
IV. Phebe, daughter of Israel Horton and Anna Van Devort, born in
Orange Co., N. Y., 6 March, 1786; married about 1806, to Frederick
Schenick, of Owego, N. Y., and went to Canada; nothing further is
known of her.
V. John, son of Israel Horton and Anna Van Devort, born in Orange
Co., N. Y., 26 Feb., 1788; married in Phelps, about 1810, to Rachael
Hiler. He died at Phelps, 9 Sept., 1859. She is still living.
Children, born in Phelps:
1. John M., born 30 Dec., 1819; married Mary Martin Boardman. 2. Samuel
Minnis, born 29 Oct., 1836; married Sylvia Ann Cole. 3. S. Van Rensalaer, born
11 Aug., 1829; married Rowena S. Rafter. 4. Peter Davis, born 17 April, 1826;
married Mary S. Aiken. 5. William P., born 26 Dec., 1821; married Phebe Ann
Brink. 6. Eunice, married Edgar P. Lake. 7. Ella S., married Gross. 8. Sarah,
unmarried.
VIII. Arietta, daughter of Israel Horton and Anna Van Devort, born
in Orange Co., N. Y., 28 Nov., 1794; married about 1818, to Isaac
Butler, of Phelps. She died 2 June, 1842.
Children:
1. Maria, married Eggleston. 2. Nancy, married Parshall. 3. Elizabeth, married
Parshall. 4. Sarah Ann, married Service. 5. Mahala, married Van Scoy. 6.
Amanda, married Larkin. 7. Elihu. 8. Samuel.
IX. Peter Davis, son of Israel Horton and Anna Van Devort, born in
Orange Co., N. Y., 11 Dec., 1796; married at Nelson, O., 5 May, 1830,
by Rev. Ezra Booth, to Hannah Couch, daughter of Samuel Couch and
Hannah Ferris, and born in Lee, Berkshire Co., Mass., 23 July, 1802.
He was a minister of the M. E. Church, a pious man, and an
acceptable preacher, standing fair among his brethren, and in the
community. Hannah Couch Horton died at Hubbard, Trumble Co., O.,
22 Feb., 1845, leaving three children, viz.:
1. Joseph Dempster. 2. Thirza Ann. 3. Marcus C.